Background: Inhaled bronchodilators can increase exercise capacity in chronic obstructive pulmonary disease (COPD) by reducing dynamic hyperinflation, but treatment is not always effective. This may ...

Sore throat? You have it too! Must be the city’s bad air. Whatever, early in the month, as Delhi was beset by extreme pollution, customer relations manager Jasbir Chatterjee was forced to take three ...

Intravenous salbutamol is commonly used to treat children with severe asthma unresponsive to inhaled β2-agonist therapy. However, in this setting, there is little clinical trial data demonstrating its ...

WEDNESDAY, Oct. 8, 2025 (HealthDay News) -- In children aged 5 to 15 years with mild asthma, budesonide-formoterol reliever monotherapy is superior to salbutamol for preventing asthma attacks, ...

A 2-in-1 inhaler treatment is more effective than salbutamol for preventing asthma attacks in children aged 5 to 15 and is similarly safe, a randomised controlled trial has reported.1 A combined ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...

Specialist respiratory nurse in primary care Marieke Strange advises on how to educate patients with asthma about why it is so important they swap their ‘blue’ salbutamol inhaler for a new combination ...

Aim To evaluate the effect of the short-acting beta agonists (SABAs) salbutamol on cardiovascular response rest, exercise and recovery phase. Methods This study was conducted as a randomized, ...